Since the glucose metabolic rate is decreased in the brains of AD patients during fluorodeoxyglucose positron emission tomography (FDG PET), peripheral resistance to insulin also develops in the central nervous system (CNS) [258,259]. Here, INS is linked to Alzheimer disease.